Analyst Ratings for Minerva Neurosciences (NERV)
NERV Rating Summary
NERV Price Target Summary
- Highest: $14.00 (Citizens)
- Lowest: $7.00 (H.C. Wainwright)
- Average: $10.50
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$10.50 (+134.9%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
Avg. $ Target:
$10.50 (+134.9%)
* Over Last 12-Mos
Rating Score: 6.3 / 10
Percentile Rank: 66%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/15/2026 | Citizens | Jason Butler | New Coverage | Market Outperform (N/A) |
14.00 (N/A) |
5.70 (4.47) |
-21.58% | Details |
| 11/10/2022 | H.C. Wainwright » Updated 3/12/2026 |
Douglas Tsao | Downgrade | Neutral (Buy) |
7.00 (4.00) |
3.26 (4.47) |
37.12% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
